Azatadine dimaleate is an orally bioavailable, blood-brain barrier permeable histamine H1 receptor blocker and antiviral agent. Azatadine dimaleate competes with histamine at histamine receptor sites to block histamine-mediated effects. Azatadine dimaleate inhibits SARS-CoV-2 replication and reduces the expression of interferons and pro-inflammatory genes including IL-6. Azatadine dimaleate is applicable to research related to coronavirus disease 2019 (COVID-19) and seasonal allergic rhinitis[1][2].
Molecular Weight:
522.55
Purity:
99.87
CAS Number:
[3978-86-7]
Formula:
C28H30N2O8
Target:
Histamine Receptor,SARS-CoV
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted